Related references
Note: Only part of the references are listed.Changes in Circulating Biomarkers of Muscle Atrophy, Inflammation, and Cartilage Turnover in Patients Undergoing Anterior Cruciate Ligament Reconstruction and Rehabilitation
Christopher L. Mendias et al.
AMERICAN JOURNAL OF SPORTS MEDICINE (2013)
Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
Rosamund C. Smith et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2013)
The central role of myostatin in skeletal muscle and whole body homeostasis
B. Elliott et al.
ACTA PHYSIOLOGICA (2012)
Interference with Myostatin/ActRIIB Signaling as a Therapeutic Strategy for Duchenne Muscular Dystrophy
Helge Amthor et al.
CURRENT GENE THERAPY (2012)
Immunolocalization of Myostatin (GDF-8) Following Musculoskeletal Injury and the Effects of Exogenous Myostatin on Muscle and Bone Healing
Moataz Elkasrawy et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation
Zhiqing Huang et al.
CELLULAR SIGNALLING (2011)
Intensive care unit-acquired weakness
Richard D. Griffiths et al.
CRITICAL CARE MEDICINE (2010)
Sepsis Downregulates Myostatin mRNA Levels Without Altering Myostatin Protein Levels in Skeletal Muscle
Ira J. Smith et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Recombinant Myostatin (GDF-8) Propeptide Enhances the Repair and Regeneration of Both Muscle and Bone in a Model of Deep Penetrant Musculoskeletal Injury
Mark W. Hamrick et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2010)
Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume
Ethan Kellum et al.
BONE (2009)
Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle
Adel Amirouche et al.
ENDOCRINOLOGY (2009)
Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer
Kunihiro Tsuchida et al.
ENDOCRINE JOURNAL (2008)
Muscle myostatin signalling is enhanced in experimental cancer cachexia
P. Costelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice
C-M Liu et al.
CANCER GENE THERAPY (2007)
The myostatin gene: physiology and pharmacological relevance
Dominique Joulia-Ekaza et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism
Craig McFarlane et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Prolonged underfeeding of sheep increases myostatin and myogenic regulatory factor Myf-5 in skeletal muscle while IGF-1 and myogenin are repressed
F Jeanplong et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy
KA Reardon et al.
MUSCLE & NERVE (2001)
The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation
MG Seneff et al.
CRITICAL CARE MEDICINE (2000)
Share Paper
